A research team led by Professor Chen Peng from the College of Chemistry and Molecular Engineering at Peking University has ...
The CEO of ModeX Therapeutics discusses MDX2003, a groundbreaking tetraspecific therapy that promises enhanced efficacy and ...
CD8 + cytotoxic T lymphocytes (CTLs) serve as central effectors in cancer immunotherapy by directly eliminating tumor cells. However, current clinical therapies face significant limitations. These ...
A new discovery about how cells communicate with each other in the body's immune system has revealed deeper insights for an ...
New research reports the creation of a degradation-based cancer vaccine that penetrates tumor cells and converts them into ...
Stanford University-led researchers report that tumor cells hijack mitochondria from immune cells, reducing anti-tumor immune ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results